
Naina Chipalkatti MD
Hematology/Oncology
Clinical Fellow in Hematology
Join to view full profile
350 Brookline AveBoston, MA 02115
Dr. Chipalkatti is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2025 - 2028
University of MichiganResidency, Internal Medicine, 2021 - 2024
Tufts University School of MedicineClass of 2021
Certifications & Licensure
MA State Medical License 2025 - 2027
PA State Medical License 2024 - 2026
MI State Medical License 2021 - 2024
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsOutcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study.Nelish Ardeshna, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti
The American Journal of Medicine. 2025-12-01 - 3 citationsA Comparison of Outcomes With Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism.Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti
JACC. Advances. 2025-05-01 - 5 citationsGuideline concordance of aspirin use for primary prevention in adult outpatients.Naina Chipalkatti, Geoffrey D Barnes, Linda Bashaw, Adam Davie, Jennifer J Griggs
Blood Advances. 2024-12-24
Press Mentions
Reducing Dose of Popular Blood Thinners May Limit Risk of Future BleedingDecember 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









